Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.

Authors:
Otto Cars
Otto Cars
Uppsala University
Sweden
Asa Melhus
Asa Melhus
Malmö University Hospital
Sweden

Antimicrob Agents Chemother 2010 Sep 14;54(9):3564-8. Epub 2010 Jun 14.

Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Foreign travel has been suggested to be a risk factor for the acquisition of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. To our knowledge, this has not previously been demonstrated in a prospective study. Healthy volunteers traveling outside Northern Europe were enrolled. Rectal swabs and data on potential travel-associated risk factors were collected before and after traveling. A total of 105 volunteers were enrolled. Four of them did not complete the study, and one participant carried ESBL-producing Escherichia coli before travel. Twenty-four of 100 participants with negative pretravel samples were colonized with ESBL-producing Escherichia coli after the trip. All strains produced CTX-M enzymes, mostly CTX-M-15, and some coproduced TEM or SHV enzymes. Coresistance to several antibiotic subclasses was common. Travel to India was associated with the highest risk for the acquisition of ESBLs (88%; n = 7). Gastroenteritis during the trip was an additional risk factor (P = 0.003). Five of 21 volunteers who completed the follow-up after 6 months had persistent colonization with ESBLs. This is the first prospective study demonstrating that international travel is a major risk factor for colonization with ESBL-producing Enterobacteriaceae. Considering the high acquisition rate of 24%, it is obvious that global efforts are needed to meet the emergence and spread of CTX-M enzymes and other antimicrobial resistances.

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00220-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934993PMC
September 2010
134 Reads

Publication Analysis

Top Keywords

risk factor
16
escherichia coli
12
prospective study
12
factor colonization
8
ctx-m enzymes
8
esbl-producing escherichia
8
esbl-producing enterobacteriaceae
8
foreign travel
8
major risk
8
travel major
8
risk
6
coli travel
4
high acquisition
4
participant carried
4
carried esbl-producing
4
100 participants
4
participants negative
4
negative pretravel
4
enterobacteriaceae considering
4
acquisition esbls
4

Similar Publications

Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.

Int J Med Microbiol 2015 Jan 9;305(1):148-56. Epub 2014 Dec 9.

Institute for Medical Microbiology and Epidemiology of Infectious Diseases, Leipzig University Hospital, Liebigstr. 21, D-04103 Leipzig, Germany.

Two hundred and twenty-five healthy German volunteers traveling to 53 different countries (mostly in Asia, Africa and South America) were enrolled in a prospective cohort study. Stool samples and data on potential travel-associated risk factors (such as type of travel, nutritional habits, occurrence of gastroenteritis) were collected before and after traveling. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) and carbapenemase-producing Enterobacteriaceae (CPE) was performed using selective media (CHROMagar™ ESBL/CPE plates). Read More

View Article
January 2015

Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.

Indian J Med Res 2009 Jun;129(6):695-700

Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Background & Objective: Extended spectrum beta-lactamases (ESBLs) have emerged as a major threat worldwide with limited treatment options. The genotypes of ESBL producing strains largely remain unknown in India; hence the present study was aimed to determine the occurrence of ESBLs in Escherichia coli and Klebsiella pneumoniae, their molecular types and associated risk factors in a tertiary care hospital.

Methods: Total 200 consecutive clinical isolates of E. Read More

View Article
June 2009

Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands.

Emerg Infect Dis 2013 Aug;19(8):1206-13

Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.

A prospective cohort study was performed among travelers from the Netherlands to investigate the acquisition of carbapenemase-producing Enterobacteriaceae (CP-E) and extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and associated risk factors. Questionnaires were administered and rectal swab samples were collected and tested before and after traveler return. Of 370 travelers, 32 (8. Read More

View Article
August 2013

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Scand J Infect Dis 2010 Apr;42(4):275-80

Department of Clinical Sciences, Lund University, Malmö, Swden.

The identification of patients carrying extended-spectrum beta-lactamase (ESBL)-producing bacteria is important, since these patients are at risk of receiving inappropriate empirical therapy if they become infected. The purpose of this study was to investigate the occurrence of ESBL-producing bacteria in patients with travellers' diarrhoea. Patients with travellers' diarrhoea (N = 242) having delivered stool samples for the diagnosis of Salmonella, Shigella, Yersinia or Campylobacter, were also examined for ESBL-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Read More

View Article
April 2010